Products - Skin infections | Topic | NICE

Showing 4 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Dupilumab for treating bullous pemphigoid [ID6479]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Povorcitinib for treating moderate to severe active hidradenitis suppurativa after a TNF-alpha inhibitor [ID6569]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Ruxolitinib for Prurigo Nodularis [ID6571]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Upadacitinib for treating moderate to severe hidradenitis suppurativa in people 12 years and over [ID6666]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC